INTRODUCTION 3 3
The purpose of this study is to demonstrate that human blood-derived platelets may provide critical 3 4 information about malfunctioned proteolytic machinery leading to diseased protein aggregation in a can be measured in platelets. Although the functions of autophagy within platelets are largely unclear but 8 0 thus far, it is known that, its impairment leads to a lack of platelet aggregation and adhesion [12] . 8 1 We have demonstrated that a TAR-DNA/RNA binding protein (TDP-43) and its phosphorylated 8 2 derivative (pTDP-43) levels were elevated in platelets obtained from AD patients as part of the were imaged by Odyssey (LI-COR) imaging system at the 700 nm set channel. The staining 1 4 8 was optionally removed by incubating with REVERT reversal solution for a maximum of 10 1 4 9 minutes as per protocol, then finally rinsed twice with nanopure water. The membrane was 1 5 0 blocked in 2 mL of 1:1 Seablock /TBS buffer for 1 hour at room temperature (RT) on an orbital 1 5 1 shaker. Afterwards, the membrane is directly transferred to a container with 10 mL of 1:1 1 5 2
Seablock/TBST and primary antibody dilution in1:500 or 1:1000 while incubating on an orbital 1 5 3
shaker for overnight (at least 12 hours) at 4℃. Next day, the membrane was washed with 1X 1 5 4
TBST for 20-minutes then incubated horseradish peroxidase conjugated secondary antibody, 1 5 5 goat anti-mouse (LC3) and goat anti-rabbit (P62, Beclin-1, and Atg5-12) at 1:10,000 dilution 1 5 6
for 1 hour at RT on an orbital shaker. Additional 20-minutes wash with 1x TBST was 1 5 7 performed to remove unbound antibodies prior to imaging was completed. The membrane was Image Studio Lite (Ver.4.0). We have tested a battery of antibodies for probing autophagy protein purchased from three different three replicates averaged and independently tested as an interval type of data. We only found an increase The proteasome concentrations of platelet lysates from AD and age-matched control subjects (n=12) 1 9 0 were 1 9 1 assessed by ELISA method. Although AD patient platelet lysate proteasome levels were elevated, no Aβ 1-42 is widely understood to accumulate in the early stages of the AD pathology. This malfunctioning 2 0 8 protein recruits and triggers microglial, astrocyte facilitated clearance, but soon Aβ 1-42 depositions 2 0 9 overwhelm the response leading to microglia-mediated neuroinflammation [14] [15] [16] Aβ 1-42 also stimulates the disease, somehow the proteolytic system is suppressed due to downregulation [2, 6] , allowing for the 2 1 4 characteristic extracellular amyloid plaques and neurofibrillary tangles to develop. Some reports also recently discovered that platelets contain a proteolytic system by which hemostasis and 2 1 6 thrombosis is acquired [17, 18] . Since it was also discovered that an elevation of pathological pTDP43 within 2 1 7 the platelet cytosol is correlated to hippocampal cortex of AD patients [13] , it was imperative that we 2 1 8 analyze these platelet proteolytic systems. We attempted to establish any change of the protein 2 1 9 concentrations of proteolytic system, since platelet proteasome concentrations have not been reported prior
to our studies. It was initially believed and hypothesized, based on aforementioned reports, the proteolytic 2 2 1 system is somehow altered and that we would expect to observe some degree of variations in proteasome 2 2 2 concentrations.
3
In specific aim-1, certain autophagy marker antibodies (i.e. Beclin-1, Atg5, p62, and LC3) were analyzed 2 2 4
for autophagy forming proteins in platelets. This was in reference to previous autophagy activity measurements by Gupta eta al [17] .The antibodies from multiple manufacturers have different affinities for to match the best antibody /protein combination to be used in the assays. Those results suggested 30 μ g 2 2 8
whole platelet lysate proteins paired with a primary antibody dilution of 1:1000 was ideal for future 2 2 9 analysis.
Next, we evaluated only LC3A and LC3B antibodies in Western blotting.These findings distinguished that components exhibit distinct expression patterns in different human tissues [19] . After the final 2 3 4 measurement of three replicates, the only reasonable results found were the proteins levels of LC3-I (a 2 3 5 cleaved form of LC3). LC3-II (lipidated LC3-I) is a conjugated protein marker for platelet autophagy 2 3 6 system [20] .Since there was no change in levels of LC3-II, the difference in LC3-I between the groups (p ≤ 2 3 7 0.021) could be a result of autophagic pathway being blocked in its initial steps in AD [21] . The overarching 2 3 8
implication we believe is that in AD, probably to alleviate aggregate stress, platelet allocated autophagy 2 3 9 may be functionally upregulated and induced but inhibited in early or late steps of the pathway [20] . By only 2 4 0
immunoblotting the for LC3, our results are more likely inconclusive. The immunoreactivity of LC3-I and 2 4 1 LC3-II are different. LC3-II tends to be more sensitive to antibodies [21] . A stimulated autophagic pathway 2 4 2 is represented by reduction of autophagy marker LC3II. So, when we analyzed that there was no change in activity analysis assessment should be performed in freshly isolated intact platelets. In specific aim-2, we assessed the proteasome concentration in platelet lysates. Poteasome 20S protein To assess the relationship of platelet proteolytic machinery protein levels in AD more effectively than the 2 5 2 use of only p values we incorporated effect sizes [22, 23] . In addition to selecting a student t-test (interval, 2 5 3 parametric), we also stepped down to a Mann-Whitney (ordinal, non-parametric) level of measurement. variances. This adjustment ascribed the data into ranked categories before comparing the median values 2 5 7 between the groups. Despite the statistical insignificance between the two groups means of Atg5-12, p62, Beclin-1, a measure Denoting a probability that there is a difference in autophagic pathway protein levels, but our sample is not 2 6 2 large enough to produce statistical significance. On the other hand, the insignificance found between AD 2 6 3 and control regarding LC3-II protein bands was coincided with a small magnitude of effect between 2 6 4 groups. (d = 0.27, R = 0.13, p = 0.58) (Fig.1B ) About proteasome testing (p = 0.373) its statistical 2 6 5
insignificance was also matched with a small group effect (d = 0.34, R = 0.17). In retrospect, there are some caveats and setbacks, largely rendering our results with a low difference. First, samples [24] . Secondly, as it has been reported that LC3-I is unstable and sensitive to freezing-thawing 2 7 3 cycles or SDS buffered cocktail [25] . Future samples should be freshly assessed and not exposed to a repeated freeze-thaw cycle. Thirdly, immunoblotting has its limitation of determining autophagic 2 7 5
fluctuations. As we understand that LC3-II is the go-to marker, an increase in its presence could be due to 2 7 6 several reasons. It could probably correlate with autophagosome accumulation but autophagic flux is not 2 7 7
guaranteed [26] . In more relevance to AD neuropathology, beclin-1 is downregulated in this disease; 2 7 8 however, LC3-II can still form without a phagophore and on ectopic membranes [21, 25] . It is known that a neurodegenerative condition such as AD effects the periphery by increase in thrombin 2 8 0 and von Willebrand factor (vWF) protein. Thrombin and vWF are platelet activators [18] . In AD, the 2 8 1 patients are known to express an increased amount of vWF, which is partially used to convert quiescent 2 8 2 platelets into activated platelets [27] . Hence, activated platelets of these patients produce and release more 2 8 3
Aβ into circulation compared to the controls [28] . Aβ usually interacts with fibrin thereby promoting 2 8 4 coagulation and fibrin aggregation. Therefore, an increase of Aβ could mean an increase in platelet 2 8 5 aggregation that implies an alternate flux in hemostasis. We did not analyze Aβ peptide levels in platelet 2 8 6 lysates of AD patients and age-matched control subjects in this study; however, we plan to include the 2 8 7 platelet lysate Aβ 1-42 measurements in a follow-up study 2 8 8
Since our results are supposed to be a testament of basal autophagy in quiescent platelets, AD derived increased autophagic pathway activity [18] . Therefore, the significant measurements might be due to that 2 9 1 previous condition. The best way to adjust for that variable would be activate the control platelets before 2 9 2 any protein concentration measurements. An alternative approach would be to inhibit the platelet 2 9 3 activation factor by including an inhibitor (PGI2) during the platelet isolation from whole blood. Platelet 2 9 4
proteolytic system analysis has allowed us to differentiate probable proteostasis between probable AD and 2 9 5 control in cross-sectional fashion. It is clear that the elevated presence of TDP-43 is equally represented in 2 9 6 AD brain homogenate segments of the hippocampus and isolated platelet lysates [13] . One of the 2 9 7 possibilities that can be discerned from our study is that there may be elevated induction of autophagy, 2 9 8 beyond basal amount. With a higher probability, somewhere along the autophagic pathway, there is 2 9 9
suppression of progression into the pathway. In light of this information, platelet autophagic profile may be similar to neurons of this disease profile. This study was meant to extrapolate the extent to which AD can influence the state of these systems during Agbas, A conceptualized the study, analyzed the data, and wrote the manuscript 3 1 3 Research reported in this publication was supported by several pilot project funds from QS85523J, financial involvement with any organization or entity with a financial interest in or financial conflict with 
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